247 related articles for article (PubMed ID: 22457281)
1. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses.
Krepstakies M; Lucifora J; Nagel CH; Zeisel MB; Holstermann B; Hohenberg H; Kowalski I; Gutsmann T; Baumert TF; Brandenburg K; Hauber J; Protzer U
J Infect Dis; 2012 Jun; 205(11):1654-64. PubMed ID: 22457281
[TBL] [Abstract][Full Text] [Related]
2. Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.
Habersetzer F; Leboeuf C; Doffoël M; Zeisel MB; Baumert TF
Expert Opin Investig Drugs; 2013 Jul; 22(7):853-62. PubMed ID: 23634817
[TBL] [Abstract][Full Text] [Related]
3. A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
Hoffmann J; Schneider C; Heinbockel L; Brandenburg K; Reimer R; Gabriel G
Antiviral Res; 2014 Apr; 104():23-33. PubMed ID: 24486207
[TBL] [Abstract][Full Text] [Related]
4. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
5. A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.
Colpitts CC; Schang LM
J Virol; 2014 Jul; 88(14):7806-17. PubMed ID: 24789779
[TBL] [Abstract][Full Text] [Related]
6. Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate.
Luganini A; Giuliani A; Pirri G; Pizzuto L; Landolfo S; Gribaudo G
Antiviral Res; 2010 Mar; 85(3):532-40. PubMed ID: 20083141
[TBL] [Abstract][Full Text] [Related]
7. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
8. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
[TBL] [Abstract][Full Text] [Related]
9. [Peptides--a new strategy for combating viral infections].
Kołodziej M; Joniec J; Bartoszcze M; Mirski T; Gryko R
Przegl Epidemiol; 2011; 65(3):477-82. PubMed ID: 22184952
[TBL] [Abstract][Full Text] [Related]
10. Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions.
Bertaux C; Daelemans D; Meertens L; Cormier EG; Reinus JF; Peumans WJ; Van Damme EJ; Igarashi Y; Oki T; Schols D; Dragic T; Balzarini J
Virology; 2007 Sep; 366(1):40-50. PubMed ID: 17498767
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
12. Ge-Gen-Tang has anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines.
Chang JS; Wang KC; Shieh DE; Hsu FF; Chiang LC
J Ethnopharmacol; 2012 Jan; 139(1):305-10. PubMed ID: 22120014
[TBL] [Abstract][Full Text] [Related]
13. Strategies for antiviral screening targeting early steps of virus infection.
Peng T
Virol Sin; 2010 Aug; 25(4):281-93. PubMed ID: 20960301
[TBL] [Abstract][Full Text] [Related]
14. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses.
Yuan L; Zhang S; Wang Y; Li Y; Wang X; Yang Q
J Virol; 2018 Nov; 92(21):. PubMed ID: 30068648
[TBL] [Abstract][Full Text] [Related]
15. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
Hong HW; Lee SW; Myung H
J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
[TBL] [Abstract][Full Text] [Related]
16. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
[TBL] [Abstract][Full Text] [Related]
17. Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.
Esimone CO; Grunwald T; Nworu CS; Kuate S; Proksch P; Uberla K
Chemotherapy; 2009; 55(2):119-26. PubMed ID: 19155620
[TBL] [Abstract][Full Text] [Related]
18. Peptide inhibitors against influenza virus.
Rajik M; Yusoff K
Antivir Chem Chemother; 2011 Mar; 21(4):151-4. PubMed ID: 21602612
[TBL] [Abstract][Full Text] [Related]
19. Virus-inhibiting surgical glove to reduce the risk of infection by enveloped viruses.
Bricout F; Moraillon A; Sonntag P; Hoerner P; Blackwelder W; Plotkin S
J Med Virol; 2003 Apr; 69(4):538-45. PubMed ID: 12601762
[TBL] [Abstract][Full Text] [Related]
20. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.
Rusnati M; Vicenzi E; Donalisio M; Oreste P; Landolfo S; Lembo D
Pharmacol Ther; 2009 Sep; 123(3):310-22. PubMed ID: 19447134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
